DK479587A - Eddikesyreesteren af haloperidol saavelsom farmaceutiske kompositioner deraf - Google Patents

Eddikesyreesteren af haloperidol saavelsom farmaceutiske kompositioner deraf

Info

Publication number
DK479587A
DK479587A DK479587A DK479587A DK479587A DK 479587 A DK479587 A DK 479587A DK 479587 A DK479587 A DK 479587A DK 479587 A DK479587 A DK 479587A DK 479587 A DK479587 A DK 479587A
Authority
DK
Denmark
Prior art keywords
haloperidol
pharmaceutical compositions
acetic acid
saavels
estate
Prior art date
Application number
DK479587A
Other languages
English (en)
Other versions
DK166320C (da
DK166320B (da
DK479587D0 (da
Inventor
Jens Kristian Perregaard
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of DK479587D0 publication Critical patent/DK479587D0/da
Publication of DK479587A publication Critical patent/DK479587A/da
Publication of DK166320B publication Critical patent/DK166320B/da
Application granted granted Critical
Publication of DK166320C publication Critical patent/DK166320C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)
DK479587A 1986-09-11 1987-09-11 Eddikesyreesteren af haloperidol, fremgangsmaade til fremstilling heraf og farmaceutiske kompositioner deraf DK166320C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868621892A GB8621892D0 (en) 1986-09-11 1986-09-11 Organic compound
GB8621892 1986-09-11

Publications (4)

Publication Number Publication Date
DK479587D0 DK479587D0 (da) 1987-09-11
DK479587A true DK479587A (da) 1988-03-12
DK166320B DK166320B (da) 1993-04-05
DK166320C DK166320C (da) 1993-08-23

Family

ID=10604021

Family Applications (1)

Application Number Title Priority Date Filing Date
DK479587A DK166320C (da) 1986-09-11 1987-09-11 Eddikesyreesteren af haloperidol, fremgangsmaade til fremstilling heraf og farmaceutiske kompositioner deraf

Country Status (16)

Country Link
US (1) US4855307A (da)
EP (1) EP0260070B1 (da)
JP (1) JPS6377857A (da)
AT (1) ATE92917T1 (da)
AU (1) AU591334B2 (da)
DE (1) DE3786966T2 (da)
DK (1) DK166320C (da)
ES (1) ES2058120T3 (da)
FI (1) FI88155C (da)
GB (1) GB8621892D0 (da)
IE (1) IE60902B1 (da)
IL (1) IL83819A (da)
NO (1) NO169893C (da)
NZ (1) NZ221711A (da)
PT (1) PT85678B (da)
ZA (1) ZA876819B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3742580C1 (de) * 1987-12-16 1989-05-11 Schaper & Bruemmer Gmbh Verwendung des alpha,alpha-Diphenyl-alpha-(3-carboxy-propionyloxy)-essigsaeure-4-(N-methylpiperidyl)-esters zur Behandlung hypertoner Funktionszustaende im Bereich der Harnblase
US5776963A (en) 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
DK238190D0 (da) * 1990-10-03 1990-10-03 Lundbeck & Co As H Depotderivater
EP1787984B1 (en) * 2000-03-06 2016-10-19 Acadia Pharmaceuticals Inc. Azacyclic compounds for use in the treatment of serotonin related diseases
MXPA02008770A (es) 2000-03-06 2004-09-10 Acadia Pharm Inc Compuestos azaciclicos para uso en el tratamiento de enfermedades relacionadas con la serotonina.
MXPA04006280A (es) 2001-12-28 2004-09-27 Acadia Pharm Inc Compuestos espiroazaciclicos como moduladores de receptor de monoamina.
CA2490397A1 (en) 2002-06-24 2003-12-31 Acadia Pharmaceuticals Inc. N-substituted piperidine derivatives as serotonin receptor agents
US7538222B2 (en) 2002-06-24 2009-05-26 Acadia Pharmaceuticals, Inc. N-substituted piperidine derivatives as serotonin receptor agents
US7253186B2 (en) 2002-06-24 2007-08-07 Carl-Magnus Andersson N-substituted piperidine derivatives as serotonin receptor agents
WO2004064738A2 (en) 2003-01-16 2004-08-05 Acadia Pharmaceuticals Inc. Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases
US20050261278A1 (en) 2004-05-21 2005-11-24 Weiner David M Selective serotonin receptor inverse agonists as therapeutics for disease
US7820695B2 (en) 2004-05-21 2010-10-26 Acadia Pharmaceuticals, Inc. Selective serotonin receptor inverse agonists as therapeutics for disease
AU2005289635A1 (en) 2004-09-27 2006-04-06 Acadia Pharmaceuticals Inc. Salts of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide and their preparation
US7790899B2 (en) 2004-09-27 2010-09-07 Acadia Pharmaceuticals, Inc. Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms
US20090053329A1 (en) 2007-03-19 2009-02-26 Acadia Pharmaceuticals, Inc. Combinations of 5-ht2a inverse agonists and antagonists with antipsychotics
PT3325444T (pt) 2015-07-20 2021-09-22 Acadia Pharm Inc Métodos para preparar n-(4-fluorobenzil)-n-(1-metilpiperidina-4-il)-n'-(4-(2-metilpropiloxi)fenilmetil)carbamida e o seu sal de tartarato e forma polimórfica c
US10953000B2 (en) 2016-03-25 2021-03-23 Acadia Pharmaceuticals Inc. Combination of pimavanserin and cytochrome P450 modulators
WO2017165635A1 (en) 2016-03-25 2017-09-28 Acadia Pharmaceuticals Inc. Combination of pimavanserin and cytochrome p450 modulators
EP3558311A1 (en) 2016-12-20 2019-10-30 Acadia Pharmaceuticals Inc. Pimavanserin alone or in combination for use in the treatment of alzheimer's disease psychosis
EP3615028A1 (en) 2017-04-28 2020-03-04 Acadia Pharmaceuticals Inc. Pimavanserin for treating impulse control disorder
US20210077479A1 (en) 2017-08-30 2021-03-18 Acadia Pharmaceuticals Inc. Formulations of pimavanserin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB895309A (en) * 1959-11-18 1962-05-02 Res Lab Dr C Janssen Nv Pyrrolidine and piperidine derivatives
US3408356A (en) * 1965-08-31 1968-10-29 Squibb & Sons Inc Long chain esters of 4'-fluoro-4-[4-hydroxy-4-(alpha, alpha, alpha-trifluorotolyl)piperi-dino]butyrophenone and the like
DE1695194A1 (de) * 1966-07-11 1971-03-18 Hoffmann La Roche Verfahren zur Herstellung von Piperidinderivaten
US4070473A (en) * 1973-01-26 1978-01-24 Ab Ferrosan Piperidino-butyrophenones
JPS568318A (en) * 1979-06-28 1981-01-28 Janssen Pharmaceutica Nv Non oral long acting composition of haloperidol and bromperidol derivative

Also Published As

Publication number Publication date
NO873785D0 (no) 1987-09-10
GB8621892D0 (en) 1986-10-15
NZ221711A (en) 1989-11-28
IL83819A0 (en) 1988-02-29
EP0260070A1 (en) 1988-03-16
EP0260070B1 (en) 1993-08-11
DE3786966T2 (de) 1994-03-17
DK166320C (da) 1993-08-23
PT85678B (pt) 1990-05-31
DK166320B (da) 1993-04-05
US4855307A (en) 1989-08-08
NO169893C (no) 1992-08-19
NO873785L (no) 1988-03-14
ATE92917T1 (de) 1993-08-15
PT85678A (en) 1987-10-01
FI873924A0 (fi) 1987-09-10
ZA876819B (en) 1988-06-29
NO169893B (no) 1992-05-11
IL83819A (en) 1992-02-16
AU7823287A (en) 1988-03-17
IE872366L (en) 1988-03-11
IE60902B1 (en) 1994-08-24
DE3786966D1 (de) 1993-09-16
ES2058120T3 (es) 1994-11-01
FI88155B (fi) 1992-12-31
AU591334B2 (en) 1989-11-30
JPS6377857A (ja) 1988-04-08
FI88155C (fi) 1993-04-13
FI873924A (fi) 1988-03-12
DK479587D0 (da) 1987-09-11

Similar Documents

Publication Publication Date Title
DK479587A (da) Eddikesyreesteren af haloperidol saavelsom farmaceutiske kompositioner deraf
ES2074846T3 (es) Nuevas naftil-etil-ureas y naftil-etil-tioureas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
FI946104A0 (fi) Erittäin konsentroitu immunoglobuliinivalmiste ja menetelmä sen valmistamiseksi
FI20000507A (fi) (+)-1-(3-dimetyyliaminopropyyli)-1-(4'-fluorifenyyli)-1,3-dihydroisobentsofuraani-5-karbonitriili ja sitä sisältävä farmaseuttinen koostumus
KR840004741A (ko) 디히드로피리딘 유도체의 제조방법
ATE2271T1 (de) 4-(substituierte thiazolyl)-3-hydroxy-3-pyrrolin2,5-dion-verbindungen, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzung.
ES2128519T3 (es) Nuevas pirido-tiadiazinas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
DE69122866D1 (de) Herstellung von substituierten piperidinen
MX9203360A (es) Derivados de hexahidroazepinas y composiciones farmaceuticas que los contienen.
FI851932A0 (fi) --karbolin-3- karboxylsyraderivat, deras framstaellningsfoerfarande och deras anvaendning.
FI881609A (fi) Dihydropyridinamider, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
ATE92469T1 (de) Neue alpha-aminocarbonsaeure-derivate, ihre herstellung und verwendung.
DK149888C (da) Analogifremgangsmaade til fremstilling af 1-(1,3,4-oxadiazolyl-2-phenoxy)-3-(4-phenylpiperazinyl)-propan-2-oler eller fysiologisk acceptable syreadditionssalte heraf
YU45645B (sh) Postupak za dobivanje dihidropiridinskih derivata
DE3770287D1 (de) Neue n-glycosylamidderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel.
ATE90095T1 (de) Optisch aktive produkte von 20,21dinoreburnamenin-derivaten,verfahren zur herstellung, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammenstellungen.
DE69715733D1 (de) Verfahren zur Herstellung von 5-Brom-2-Fluorbenzolboronsäure
FI870994A0 (fi) Foerfarande foer framstaellning av stabila, injekterbara farmaceutiska kompositioner, vilka innehaoller 1,4-dihydroxi-5,8-bis/2-(2-hydroxietylamino)etylamino/ antrakinondihydroklorid.
SE8505801D0 (sv) 1,4-dihydropyridin-derivate, ihre herstellung und sie enthaltende pharmazeutische zubereitungen
DK468385A (da) Fremgangsmaade til fremstilling af den optiske d-isomer af diastereomeren aeaae af 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridin-3,5-dicarboxylsyre-3-(1-benzylpyrrolidin-3-yl)-ester-5-methylester
ATE4166T1 (de) Langwirkende injizierbare sulfonamidzusammensetzungen.
ATE151736T1 (de) 2-arylpropensäuren und ihre verwendung bei der herstellung von s-ketoprofen
DE59002266D1 (de) Verwendung von 4-(hydroxydi-phenylmethyl)-1-piperidyl-phenylalkan-derivaten zur herstellung eines antihistaminikums.
DK226685A (da) Estere af 1,4-dihydro-2,6-dimethyl-3-(alkoxycarbonyl eller alkoxyalkoxycarbonyl)-4-(substitueret phenyl)-pyridin-5-carboxylsyre
ATE111732T1 (de) Verwendung von 1,4-dihydropyridinen zur herstellung eines arzneimittels, zur behandlung von neuropathien, die durch diabetes mellitus verursacht sind.

Legal Events

Date Code Title Description
PBP Patent lapsed